Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg Sells 2,000 Shares

Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg sold 2,000 shares of Precipio stock in a transaction on Monday, November 11th. The shares were sold at an average price of $6.28, for a total transaction of $12,560.00. Following the completion of the transaction, the director now directly owns 16,525 shares in the company, valued at $103,777. The trade was a 10.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Precipio Price Performance

NASDAQ PRPO opened at $6.44 on Friday. The firm’s fifty day moving average is $6.47 and its two-hundred day moving average is $5.90. Precipio, Inc. has a one year low of $4.31 and a one year high of $8.49. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.73.

Precipio (NASDAQ:PRPO) last posted its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.83) earnings per share for the quarter. Precipio had a negative return on equity of 34.01% and a negative net margin of 17.23%. The company had revenue of $4.44 million for the quarter.

About Precipio

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.